Celon Pharma SA (CLN) — Cash Flow Reinvestment Rate
Celon Pharma SA (CLN) has a Cash Flow Reinvestment Rate of 0.72x as of December 2025, reinvesting zł26.48 Million (capex zł26.48 Million ) from operating cash flow of zł36.63 Million. See Celon Pharma SA (CLN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Celon Pharma SA Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Celon Pharma SA across 10 annual periods. For the full cash flow conversion analysis, see CLN cash flow metrics.
Annual Cash Flow Reinvestment Rate for Celon Pharma SA (2012–2025)
Year-by-year capital reinvestment analysis for Celon Pharma SA. See financial agility of Celon Pharma SA to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.28x | zł54.44 Million | zł23.86 Million | zł54.44 Million | ▼ -17.3% |
| 2021 | 2.76x | zł121.22 Million | zł43.95 Million | zł41.35 Million | ▲ +35.2% |
| 2020 | 2.04x | zł144.60 Million | zł70.90 Million | zł99.16 Million | ▼ -14.6% |
| 2018 | 2.39x | zł67.47 Million | zł28.24 Million | zł67.46 Million | ▲ +92.8% |
| 2017 | 1.24x | zł31.35 Million | zł25.30 Million | zł31.34 Million | ▲ +20.2% |
| 2016 | 1.03x | zł21.29 Million | zł20.65 Million | zł21.29 Million | ▲ +20.4% |
| 2015 | 0.86x | zł44.86 Million | zł52.37 Million | zł44.86 Million | ▼ -7.5% |
| 2014 | 0.93x | zł22.55 Million | zł24.36 Million | zł22.55 Million | ▲ +38.6% |
| 2013 | 0.67x | zł5.64 Million | zł8.45 Million | zł5.64 Million | ▲ +97.8% |
| 2012 | 0.34x | zł4.34 Million | zł12.87 Million | zł4.34 Million | — |